Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai School of Medicine, Klingenstein Pavilion, 1176 Fifth Ave., 9th Floor, New York, NY, 10029, USA.
Reproductive Medicine Associates of New York, 635 Madison Ave., 10th Floor, New York, NY, 10022, USA.
J Assist Reprod Genet. 2021 Oct;38(10):2671-2678. doi: 10.1007/s10815-021-02284-0. Epub 2021 Jul 26.
To understand the clinical factors associated with embryo survival after vitrification in a cohort of human blastocysts screened by preimplantation genetic testing for aneuploidy (PGT-A).
Patient demographic, embryo, and cycle characteristics associated with failed euploid blastocyst survival were compared in a cohort of women (n = 6167) who underwent IVF-PGT-A.
Compared to those that survived warming, vitrified euploid embryos that failed to survive after warming came from IVF cycles with significantly higher estradiol levels at time of surge (2754.8 ± 1390.2 vs. 2523.1 ± 1190.6 pg/mL, p = 0.03), number of oocytes retrieved (19.6 ± 10.7 vs. 17.5 ± 9.8, p = 0.005), and basal antral follicle count (BAFC) (15.3 ± 8.5 vs. 13.9 ± 7.2, p = 0.05). Euploid embryos were less likely to survive warming if they came from cycles before 2015 (24.6% vs. 13.2%, p < 0.001), were cryopreserved on day 7 versus day 5 or 6 (9.1% vs. 3.0%, p < 0.001), underwent two trophectoderm biopsies (6.9% vs. 2.3%, p < 0.001), had a grade C inner cell mass (15.4% vs. 7.7%, p < 0.001), or were fully hatched (41.1% vs. 12.2%, p < 0.001). In the multivariate model, which controlled for relevant confounders, the association between decreased survival and increased BAFC, year of IVF cycle, double trophectoderm biopsy, and fully hatched blastocysts remained statistically significant.
Euploid embryos that are fully hatched at time of vitrification, come from patients with high ovarian reserve, or require repeat trophectoderm biopsy are less likely to survive vitrification-warming. Our results provide a framework for reproductive counseling and offer realistic expectations to patients about the number of embryos needed to achieve family building goals.
了解通过植入前遗传学检测(PGT-A)筛选的人类囊胚玻璃化冷冻后胚胎存活率与临床相关因素的关系。
对接受 IVF-PGT-A 的患者进行了一项队列研究,比较了与未存活的整倍体囊胚解冻相关的患者人口统计学、胚胎和周期特征。
与解冻后存活的囊胚相比,解冻后未能存活的玻璃化冷冻整倍体胚胎来自于雌二醇水平在激增时明显较高的 IVF 周期(2754.8±1390.2 vs. 2523.1±1190.6 pg/mL,p=0.03)、取卵数(19.6±10.7 vs. 17.5±9.8,p=0.005)和基础窦卵泡计数(BAFC)(15.3±8.5 vs. 13.9±7.2,p=0.05)更高的患者。如果整倍体胚胎来自于 2015 年前的周期(24.6% vs. 13.2%,p<0.001)、在第 7 天而非第 5 或 6 天冷冻(9.1% vs. 3.0%,p<0.001)、进行了两次滋养外胚层活检(6.9% vs. 2.3%,p<0.001)、内细胞团质量分级为 C(15.4% vs. 7.7%,p<0.001)或完全孵出(41.1% vs. 12.2%,p<0.001),则解冻后胚胎更有可能无法存活。在控制了相关混杂因素的多变量模型中,与存活率降低相关的 BAFC 增加、IVF 周期年份、双滋养外胚层活检和完全孵出的囊胚之间的关联仍然具有统计学意义。
在玻璃化冷冻时完全孵出、来自卵巢储备较高的患者或需要重复滋养外胚层活检的整倍体胚胎,其玻璃化冷冻-解冻后存活的可能性较小。我们的结果为生殖咨询提供了一个框架,并为患者实现家庭建设目标所需的胚胎数量提供了现实的预期。